GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Memphasys Ltd (FRA:IG7) » Definitions » E10

Memphasys (FRA:IG7) E10 : €0.00 (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Memphasys E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Memphasys's adjusted earnings per share data for the fiscal year that ended in Jun. 2024 was €-0.001. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.00 for the trailing ten years ended in Jun. 2024.

During the past 3 years, the average E10 Growth Rate was 37.00% per year. During the past 5 years, the average E10 Growth Rate was 23.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Memphasys was 65.70% per year. The lowest was 9.10% per year. And the median was 37.00% per year.

As of today (2024-12-14), Memphasys's current stock price is € 0.003. Memphasys's E10 for the fiscal year that ended in Jun. 2024 was €0.00. Memphasys's Shiller PE Ratio of today is .


Memphasys E10 Historical Data

The historical data trend for Memphasys's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Memphasys E10 Chart

Memphasys Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.11 -0.07 -0.04 -0.02 -

Memphasys Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 - -0.02 - -

Competitive Comparison of Memphasys's E10

For the Biotechnology subindustry, Memphasys's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Memphasys's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Memphasys's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Memphasys's Shiller PE Ratio falls into.



Memphasys E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Memphasys's adjusted earnings per share data for the fiscal year that ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.001/128.9064*128.9064
=-0.001

Current CPI (Jun. 2024) = 128.9064.

Memphasys Annual Data

per_share_eps CPI Adj_EPS
201506 -0.073 99.838 -0.094
201606 -0.041 100.859 -0.052
201706 -0.021 102.809 -0.026
201806 -0.001 104.945 -0.001
201906 -0.001 106.617 -0.001
202006 0.000 106.246 0.000
202106 -0.001 110.332 -0.001
202206 -0.002 117.112 -0.002
202306 -0.001 124.170 -0.001
202406 -0.001 128.906 -0.001

Add all the adjusted EPS together and divide 10 will get our e10.


Memphasys  (FRA:IG7) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Memphasys E10 Related Terms

Thank you for viewing the detailed overview of Memphasys's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Memphasys Business Description

Traded in Other Exchanges
Address
30 Richmond Road, Homebush, Sydney, NSW, AUS, 2140
Memphasys Ltd is an Australian-based emerging small-cap reproductive biotechnology company. It develops and commercializes novel reproduction and fertility solutions for humans and animals. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.

Memphasys Headlines

No Headlines